These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2788173

  • 1. Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.
    Oster W, Cicco NA, Klein H, Hirano T, Kishimoto T, Lindemann A, Mertelsmann RH, Herrmann F.
    J Clin Invest; 1989 Aug; 84(2):451-7. PubMed ID: 2788173
    [Abstract] [Full Text] [Related]

  • 2. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R, van Buitenen C, Salem M, Oosterom R, Touw I, Löwenberg B.
    Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
    [Abstract] [Full Text] [Related]

  • 3. Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.
    Brach MA, Gruss HJ, Asano Y, de Vos S, Ludwig WD, Mertelsmann R, Herrmann F.
    Cancer Res; 1992 Apr 15; 52(8):2197-201. PubMed ID: 1373106
    [Abstract] [Full Text] [Related]

  • 4. Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1 beta in the autonomous growth of acute myeloblastic leukaemia cells--studies using purified CD34-positive cells.
    Bradbury D, Rogers S, Reilly IA, Kozlowski R, Russell NH.
    Leukemia; 1992 Jun 15; 6(6):562-6. PubMed ID: 1376378
    [Abstract] [Full Text] [Related]

  • 5. Control of blast cell proliferation and differentiation in acute myelogenous leukemia by soluble polypeptide growth factors.
    Herrmann F, Oster W, Mertelsmann R.
    Klin Padiatr; 1990 Jun 15; 202(4):212-7. PubMed ID: 2203937
    [Abstract] [Full Text] [Related]

  • 6. Role of colony-stimulating factors in the biology of acute myelogenous leukemia.
    Oster W, Mertelsmann R, Herrmann F.
    Int J Cell Cloning; 1989 Jan 15; 7(1):13-29. PubMed ID: 2645373
    [Abstract] [Full Text] [Related]

  • 7. Growth potentiating activity of endogenous production of interleukin-1 and tumor necrosis factor alpha in blast cells of acute myeloblastic leukemia.
    Murohashi I, Tohda S, Imai Y, Hirai Y, Nara N.
    Exp Hematol; 1993 Jul 15; 21(7):846-51. PubMed ID: 8319777
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
    Santoli D, Yang YC, Clark SC, Kreider BL, Caracciolo D, Rovera G.
    J Immunol; 1987 Nov 15; 139(10):3348-54. PubMed ID: 3500218
    [Abstract] [Full Text] [Related]

  • 14. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
    Kurzrock R, Kantarjian H, Wetzler M, Estrov Z, Estey E, Troutman-Worden K, Gutterman JU, Talpaz M.
    Exp Hematol; 1993 Jan 15; 21(1):80-5. PubMed ID: 8417962
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of growth factor expression in acute myeloid leukemia (AML).
    Fiedler W, Suciu E, Wittlief C, Ostertag W, Hossfeld DK.
    Leukemia; 1990 Jul 15; 4(7):459-61. PubMed ID: 2197515
    [Abstract] [Full Text] [Related]

  • 16. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R, Andreeff M.
    Cytokines Mol Ther; 1996 Sep 15; 2(3):147-59. PubMed ID: 9384699
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RC.
    Cancer Res; 1993 Apr 15; 53(8):1939-44. PubMed ID: 8385577
    [Abstract] [Full Text] [Related]

  • 18. Role of suramin as an IL-1 inhibitor in suppression of acute myelogenous leukemia progenitor proliferation.
    Estrov Z, Talpaz M, Estey EH, Strassmann G.
    Exp Hematol; 1995 Sep 15; 23(10):1080-7. PubMed ID: 7544738
    [Abstract] [Full Text] [Related]

  • 19. Effect of granulocyte-macrophage colony-stimulating growth factor on interferon and tumor necrosis factor production in whole blood cell cultures of patients with acute myelogenous leukemia.
    Kamińska T, Hus I, Dmoszyńska A, Kandefer-Szerszeń M.
    Arch Immunol Ther Exp (Warsz); 2001 Sep 15; 49 Suppl 2():S83-7. PubMed ID: 11665752
    [Abstract] [Full Text] [Related]

  • 20. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K, Urawa H, Tamatani T, Iwamura Y, Hashimoto T, Baba T, Suzuki H, Yamada M, Yamamoto S, Oppenheim JJ.
    J Immunol; 1988 Jan 01; 140(1):112-9. PubMed ID: 3275716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.